Coronavirus

>

Latest News

FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years

July 10th 2025

Moderna’s Spikevax receives full FDA approval for use in children at increased risk for COVID-19, expanding protection ahead of the 2025–2026 virus season.

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds
Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

July 7th 2025

Image courtesy of Cincinnati Children's
Intranasal COVID-19 Vaccine Found Safe and Immunogenic in Open Label Phase 1 Clinical Trial

July 7th 2025

What, Exactly, is Alcohol Use Disorder?
What, Exactly, is Alcohol Use Disorder?

June 16th 2025

Kennedy's First Pass at US Vaccine Policy: ACIP Guidance Reversed, Clinical Trials Amended, WHO Abandoned / image credit ©Rafael Henrique/stock.adobe.com
Kennedy's First Pass at US Vaccine Policy: ACIP Guidance Reversed, Clinical Trials Amended, WHO Abandoned

June 2nd 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.